Development and pilot testing of guidelines to monitor high-risk medications in the ambulatory setting

American Journal of Managed Care

Volumn 16, Issue 7, 2010, Pages 489-496

  Tjia, Jennifer ^a,b   Field, Terry S ^a,b   Garber, Lawrence D ^c   Donovan, Jennifer L ^d   Kanaan, Abir O ^d   Raebel, Marsha A ^e   Zhao, Yanfang ^b   Fuller, Jacquelyne C ^b   Gagne, Shawn J ^a   Fischer, Shira H ^a   Gurwitz, Jerry H ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Fallon Clinic   (United States)

^d MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^e KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALLOPURINOL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; AZATHIOPRINE; CARBAMAZEPINE; COLCHICINE; CYCLOSPORIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FENOFIBRATE; GEMFIBROZIL; IMIDAZOLE; ISONIAZID; LITHIUM; METFORMIN; METHOTREXATE; METHYLDOPA; NEFAZODONE; NICOTINIC ACID; PHENOBARBITAL; PHENYTOIN; POTASSIUM SPARING DIURETIC AGENT; QUINIDINE; RIFAMPICIN; TERBINAFINE; THEOPHYLLINE; VALPROIC ACID; WARFARIN; DRUG;

ADULT; ARTICLE; CONSENSUS DEVELOPMENT; DELPHI STUDY; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; HUMAN; INTERDISCIPLINARY RESEARCH; INTERNET; NONPARAMETRIC TEST; PATIENT SAFETY; PILOT STUDY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; CLASSIFICATION; OUTPATIENT DEPARTMENT; PROCEDURES; SAFETY; STANDARDS; UNITED STATES;

AMBULATORY CARE FACILITIES; DRUG MONITORING; GUIDELINES AS TOPIC; HUMANS; NEW ENGLAND; PHARMACEUTICAL PREPARATIONS; PILOT PROJECTS; SAFETY MANAGEMENT;

EID: 77955500891     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107-1116.
2. Matheny ME, Sequist TD, Seger AC, et al. A randomized trial of electronic clinical reminders to improve medication laboratory monitoring. J Am Med Inform Assoc. 2008;15(4):424-429.
3. Hunt SA, Abraham WT, Chin MH, et al; American College of Cardiology, American Heart Association Task Force on Practice Guidelines, American College of Chest Physicians, International Society for Heart and LungTransplantation, Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and LungTransplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154-e235.
4. Shrank WH, Polinski JM, Avom J. Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc. 2007;55(suppl 2):S373-S382. (Pubitemid 47515348)
5. National Committee for Quality Assurance. NQF-endorsed measures. 2008. http://www.ncqa.org/tabid/59/Default.aspx. Accessed November 16, 2009.
6. Raebel MA, Lyons EE, Andrade SE, et al. Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med. 2005;20(12):1120-1126.
7. Raebel MA, Lyons EE, Chester EA, et al. Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial. Arch Intern Med. 2005;165(20):2395-2401.
8. Raebel MA, Chester EA, Newsom EE, et al. Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients. Pharmacotherapy. 2006;26(5):619-626.
9. Dalbeth N, Stamp L. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events. Semin Dial. 2007;20(5):391-395.
10. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA. 2006;296(15):1858-1866.
11. Feldstein AC, Smith DH, Perrin N, et al. Improved therapeutic monitoring with several interventions: a randomized trial. Arch Intern Med. 2006;166(17):1848-1854. (Pubitemid 44455167)
12. Wagner AK, Chan KA, Dashevsky I, et al. FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf. 2006;15(6):369-386.
13. Powell C. The Delphi technique: myths and realities. J Adv Nurs. 2003;41(4):376-382.
14. Micromedex Healthcare Series [online database]. Greenwood Village, CO: Thomson Reuters (Healthcare) Inc; 2009.
15. UpToDate Inc [online database]. Waltham, MA: UpToDate Inc; 2009.
16. Pharmacist's Letter. Stockton, CA: Therapeutic Research Center; 2009.
17. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;4(1):87-90.
18. Handler SM, Shirts BH, Perera S, Becich MJ, Castle NG, Hanlon JT. Frequency of laboratory monitoring of chronic medications administered to nursing facility residents: results of a national Internet-based study. Consult Pharm. 2008;23(5):387-395. (Pubitemid 351671623)
19. Jones GC, Macklin JP, Alexander WD. Contraindications to the use of metformin. BMJ. 2003;326(7379):4-5.
20. Aronson JK, Hardman M. ABC of monitoring drug therapy: digoxin. BMJ. 1992;305(6862):1149-1152.
21. Palen TE, Raebel M, Lyons E, Magid DM. Evaluation of laboratory monitoring alerts within a computerized physician order entry system for medication orders. Am J Manag Care. 2006;12(7):389-395. (Pubitemid 44061011)
22. Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med. 1991;91(5):507-511.
23. Raebel MA, Carroll NM, Simon SR, et al. Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs. J Manag Care Pharm. 2006;12(8):656-664.
24. Hewitt M, Petitti D, eds. Interpreting the Volume-Outcome Relationship in the Context of Health Care Quality. Washington, DC: National Academy Press; 2001.
25. Turchin A, Shubina M, Pendergrass ML. Relationship of physician volume with process measures and outcomes in diabetes. Diabetes Care. 2007;30(6):1442-1447. (Pubitemid 46871152)
26. Leape LL. A systems analysis approach to medical error. J Eval Clin Pract. 1997;3(3):213-222. (Pubitemid 127499689)
27. National Committee for Quality Assurance. HEDIS 2009: Healthcare Effectiveness Data & Information Set. Vol 1. Washington, DC: National Committee for Quality Assurance; 2008. Narrative.